Melanoma Drug Prolonged Patients’ Lives in Clinical Trial
Posted by: Derya on: January 24, 2011
Advanced melanoma patients taking an experimental drug aimed at a particular mutation in their tumors lived longer than patients who did not receive the drug in a decisive clinical trial, the drug’s manufacturer, Roche, said Wednesday.
via Melanoma Drug Prolonged Patients’ Lives in Clinical Trial – NYTimes.com.
Advertisement
Leave a Reply
Medical Professional Database Award
Visitors Now
Advances in Nanotechnology
- IEEE Spectrum: American Chemical Society Touts Nanobots as Nanotechnology’s Big Impact
- New force-fluorescence device measures motion previously undetectable
- Photon-transistors for the supercomputers of the future
- Tumors gobble up nanoparticles
- Silicon nanoparticles enhance performance of solar cells
- Beyond batteries: Storing power in a sheet of paper
- Anthrax vaccine produces immunity with nanoparticles, not needles
- Computing breakthrough could elevate security to unprecedented levels
- Nanoscale blasting adjusts resistance in magnetic sensors
- Researchers develop method for mass production of nanogap electrodes
Flickr Photos
|
Maps
Recent Comments